In a previous article, I discussed three exciting ways that Google (NASDAQ: GOOG ) was revolutionizing the health care industry via new investments in biotech, medical devices, and electronic health records (EHRs). However, Google's (NASDAQ: GOOG ) chief rival in smartphones and tablets, Apple (NASDAQ: AAPL ) , also has some grand plans of its own for expanding into the health care industry.
Let's take a look at three ways Apple (NASDAQ: AAPL ) could expand its footprint into health care, and how they could alter the path of a company mainly supported by sales of the iPhone and the iPad.
1. iOS 8: Apple's launchpad into consumer health care
According to a recent report at 9to5mac, Apple's (NASDAQ: AAPL ) long-rumored iWatch will run on iOS 8, which will be designed with personal fitness in mind.
Apple's (NASDAQ: AAPL ) iOS 8 health care plans reportedly center around an app codenamed "Healthbook," which monitors fitness statistics such as steps taken, miles walked, calories burned, and weight loss. However, the app goes one step beyond fitness bands like Nike's�FuelBand and Jawbone's Up -- "Healthbook" can reportedly even monitor vital signs such as blood pressure, heart rate, hydration levels, and glucose levels.
Hot Value Companies To Own For 2015: Nyxio Technologies Corp (NYXO)
Nyxio Technologies Corporation, incorporated on June 08, 2006, through its wholly owned subsidiary Nyxio Technologies Inc. (Nyxio), develop and provide technology for the entertainment and commercial markets within the consumer electronic industry. The Company�� product includes VioSphere Smart television (TV), a flat screen TV with a fully integrated personal computer.
The Realm is an all in one personal computer (PC)/ TV, combining the latest in PC technology with high definition (HD) TV. The Realm Pro, which is all in One PC/TV geared for commercial and digital signage markets. Venture MMV, which is a mobile media viewer is a new class of video eyewear offering designer styling in a sleek ergonomic design with features and performance. The Vuzion is a TV with Android operating system (OS) built in enabling 400,000 Android applications on a TV.
The Company competes with Sony, Samsung, LG, Vizio, Apple, Dell, and HP.
Advisors' Opinion:- [By Peter Graham]
Nyxio Technologies Corp (OTCMKTS: NYXO), COREwafer Industries Inc (OTCMKTS: WAFR) and NanoTech Entertainment, Inc (OTCMKTS: NTEK) are three small cap stocks in some very diverse industries. In fact, one of these stocks just bought a 3D ice sculpture business. So will investors see their investment melt with that small cap stock�along with the other two? Here is a closer look to help you decide for yourself:��
Best Tech Stocks To Own Right Now: Quadrant 4 Systems Corp (QFOR)
Quandrant4 Systems Corp., formerly Zolon Corporation, incorporated on May 9, 1990, is focused in the information technology (IT) sector as a provider of Software as a Service (SaaS) based technology products to enterprise customers in addition to custom software development, life cycle maintenance, outsourcing and consulting services. The Company intends to provide IT consulting services; managed services; software product architecture; software development, maintenance and outsourcing and industry-specific software solutions primarily to enterprises engaged in the Financial Services, Retail and Healthcare sectors, but not limited to, IT services/solutions, managed services, software product architecture, development, maintenance and outsourcing, IT consulting and specific industry-focused software products and/or technology. On July 1, 2011, the Company merged VSG Acquisition Corp. and Resource Mine Acquisition Corp. into ISS Acquisition Corporation, all wholly-owned subsidiaries, which was then, renamed Quadrant 4 Consulting, Inc. Effective February 26, 2013, the Company acquired BlazerFish LLC, Teledata Technology Solutions Inc and Momentum Mobility.
Financial Services
The Company recognizes the changing regulatory environment as well as trends in the interaction between financial services providers and their customers and the role of technology and business-process solutions. It helps its customers implement customer-relationship-management tools based on newer trends and technology. Ite also helps its customers develop and maintain their technology infrastructure in light of regulatory factors, investing markets and demands for analysis.
Health Care and Life Sciences
In the Healthcare sector, the Company represent marketing opportunities. These opportunities are in part driven by regulatory climate while both payers and providers are recognizing that new set of technologies can play a role in achieving additional cost savings and efficiencies. I! t helps its customers integrate their needs of providing Healthcare services, managing information, managing preventive health services with the ever-increasing regulatory framework in which Healthcare services are provided. Its consulting services help customers deliver Healthcare or financing for Healthcare to get the affordability and availability to the patients using technology and business-processes in the areas of records management, billing, back-office services and service-provision analysis.
The Company competes with Accenture, IBM Global Services and Cap Gemini.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks 7 Star Entertainment Inc (OTCMKTS: SAEE), Quadrant 4 Systems Corp (OTCMKTS: QFOR) and Virtual Sourcing, Inc (OTCMKTS: PGCX) surged or rose 35%, 18.9% and 11.27%, respectively, on Friday. Moreover, all three small cap stocks have been the subject of paid promotions albeit they have not been as heavily promoted as a number of other stocks were last week. So will these three small caps keep rising this week or head in the other direction? Here is a closer look to help you decide:
- [By idahansen]
My pick of Quadrant 4 Systems (NASDAQ: QFOR) is up more than 360% and an article in today's Wall Street Journal provides much of the story!
The article, "More Employers Overhaul Health Benefits" detailed the travails that companies are having with the onslaught of Obamacare. As the excellent Wall Street Journal article by Anna Wilde Mathews reported, major companies such as Sears Holding (NASDAQ: SHLD), Darden Restaurants (NYSE: DRI), and others are revising the way employees receive health insurance and other benefits. Some, such as United Parcel Services (NYSE: UPS), are dropping coverage for spouses.
- [By RedChip]
Quadrant 4 Systems (OTCQB: QFOR), a provider of informational technology software and services, is focused on four key areas that are shaping the future of business: social media, mobile technology, big-data analytics, and cloud computing. According to market research firm IDC, these four areas are expected to account for $5 trillion in spending by 2020. QFOR's solutions help blue-chip companies such as Walgreens, Ford, Citibank, and Cisco improve their efficiency and better serve their customers.
Best Tech Stocks To Own Right Now: Durata Therapeutics Inc (DRTX)
Durata Therapeutics, Inc., incorporated on November 4, 2009, is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia.
As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin. Dalbavancin achieved its primary efficacy endpoint of non-inferiority in each of these three completed Phase III clinical trials when compared to linezolid, cefazolin or vancomycin, three of the standard-of-care agents for uncomplicated skin and skin structure infections (uSSSI), and complicated skin and skin structure infections (cSSSI). Its two ongoing Phase III clinical trials are designed to compare dalbavancin to vancomycin, with an option to switch to oral linezolid, under the new FDA draft guidance.
The Company competes with Pfizer, Cubist Pharmaceuticals, Inc., Theravance, Inc., Forest Laboratories, Inc., Sanofi-Aventis Ltd., The Medicines Company, Trius Therapeutics, Inc., Cempra, Inc., Rib-X Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics AG, Tetraphase Pharmaceuticals, Inc. and Furiex Pharmaceuticals, Inc.
Advisors' Opinion:- [By Bob's Stocks]
Durata Therapeutics (DRTX) is developing Dalbavancin, a once a week, intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. The company is expected to file a NDA (New Drug Application) at any moment and MAA (Marketing Authorization Application) at the end of 2013.
- [By Lisa Levin]
Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.
Best Tech Stocks To Own Right Now: Arc Wireless Solutions Inc.(ARCW)
ARC Wireless Solutions, Inc., together with its subsidiaries, provides wireless network components and solutions in the United States. It is involved in the design, development, manufacture, marketing, and sale of antennas and related wireless communication systems, including cellular base stations, mobiles, cellulars, and flat panel antennas. The company?s products also include global positioning systems; and conformal, portable, and other antennas, as well as antenna accessories. ARC Wireless Solutions, Inc. markets its commercial line of antennas directly to distributors, installers, and retailers of antenna accessories, as well as to commercial, government, and retail markets. It offers its products under the Freedom Antenna Exsite, Omnibase, Parity, Arc Vlpa, Airbase, and And Freedom Blade brand names. The company was formerly known as Antennas America, Inc. and changed its name to ARC Wireless Solutions, Inc. in October 2000. ARC Wireless Solutions, Inc. was founded in 1987 and is based in Denver, Colorado.
Advisors' Opinion:- [By Jake L'Ecuyer]
Meanwhile, top decliners in the sector included ARC Group Worldwide (NASDAQ: ARCW), down 6.8 percent, and 8x8 (NASDAQ: EGHT), off 5.7 percent.
Top Headline
Apple (NASDAQ: AAPL) is in talks to acquire headphone maker Beats Electronics, according to a Financial Times report from Thursday afternoon. The deal is rumored to be around $3.2 billion, which would make it Apple's largest acquisition to date.
Best Tech Stocks To Own Right Now: Organovo Holdings Inc (ONVO)
Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.
The Company has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.
The Company�� NovoGen MMX Bioprinter is an automate! d device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.
The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.
Advisors' Opinion:- [By James E. Brumley]
I'll warn you now that if you a fan of or shareholder in Organovo Holdings Inc. (NYSEMKT:ONVO), you're not going to like what you're about to hear. Sorry, but I have to call 'em like I see 'em. And what I see with ONVO is an overbought stock ripe for a big tumble.
- [By Dan Caplinger]
The stock market fought its way back from early losses on Friday, with investors taking heart from positive economic data, even as they prepared for the beginning of a new earnings season in the next couple of weeks. At least for now, it appears that policy makers will do their utmost to prevent any huge disruption in the stock market, and that boded well for shareholders today. In particular, shares of Universal Display (NASDAQ: OLED ) , Taseko Mines (NYSEMKT: TGB ) , and Organovo Holdings (NYSEMKT: ONVO ) were among the best performers of the day, with their excitement helping to carry the whole market higher.
Best Tech Stocks To Own Right Now: RingCentral Inc (RNG)
RingCentral, Inc., incorporated on February 9, 1999, is a provider of software-as-a-service (SaaS) solutions for business communications. RingCentral Office, the Company�� flagship service, is a multi-user, enterprise-grade communications solution that enables its customers and their employees to communicate through voice, text and fax, on multiple devices, including Smartphone��, tablets, personal computers (PCs) and desk phones. The Company also offer RingCentral Professional, primarily an inbound call routing service with additional text and fax capabilities targeting smaller deployments, and RingCentral Fax, an Internet fax service that permits sending and receiving faxes over the Internet.
The Company�� solutions have been developed with a mobile-centric approach and can be configured, managed and used from a Smartphone or tablet. The Company�� solutions generally use existing broadband connections. The Company�� cloud-based business communications solutions provide a single user identity across multiple locations and devices, including smartphone, tablets, PCs and desk phones, and allow for communication across multiple channels, including voice, text and fax. The Company primarily generate revenues by selling subscriptions for our cloud-based services.
The Company competes with Alcatel-Lucent, S.A., Avaya Inc., Cisco Systems, Inc., Mitel Networks Corporation, ShoreTel, Inc., Siemens Enterprise Networks, LLC, Microsoft Corporation, Broadsoft, Inc., AT&T Inc., Verizon Communications Inc., Comcast Corporation, j2 Global, Inc., 8x8, Inc., Google Inc., Yahoo! Inc. and Amazon.com.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: J.C. Penney Co. Inc. (NYSE: JCP) is down 13.9% at $8.97 after a secondary stock offering�that might have been designed to drive out short sellers. Violin Memory Inc. (NASDAQ: VMEM) is down 21% at $7.11 on a lousy IPO�day. RingCentral Inc. (NYSE: RNG) is up 39.5% at $18.14 on a good IPO day.
No comments:
Post a Comment